Skip to content
‹ Back to IndustriesSciences

The Negative Public Perception of Nuclear Energy is Posing More Risks Than Its Actual Threat

Despite being in the age of information, misinformation can often cast a longer shadow especially pertaining to the perception of nuclear energy. Even with its green credentials and immense potential for reducing carbon emissions, nuclear power struggles with public perception. Currently, there are a lot of fears and misinformation with Japan’s release of…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Nick Loris · AsiaC3 SolutionsFukushimaJapan
Share

Key takeaways

01

Despite being in the age of information, misinformation can often cast a longer shadow especially pertaining to the perception of nuclear energy.

02

Even with its green credentials and immense potential for reducing carbon emissions, nuclear power struggles with public perception.

03

Currently, there are a lot of fears and misinformation with Japan’s release of…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Despite being in the age of information, misinformation can often cast a longer shadow especially pertaining to the perception of nuclear energy. Even with its green credentials and immense potential for reducing carbon emissions, nuclear power struggles with public perception. Currently, there are a lot of fears and misinformation with Japan’s release of treated wastewater from the Fukushima power plant. This is a move scientifically deemed as extremely low risk. 

Yet, countries like China, Taiwan, and South Korea have continued to ban the importation of seafood from Japan, stoking the fire of public anxiety that already disproportionately dwarfs the actual risk involved. Adding to the growing list of countries with concerns, Russia has added its voice to the conversation.

This discord between perception and reality could cripple efforts to diversify energy portfolios and meet several crucial goals. Even on the precipice of environmental disaster, it is vital that fact-based discourse leads the way. Without it there will be risk of forsaking one of the most efficient and safest forms of energy at disposal. If climate change is to be combatted while ensuring energy security, there needs to be a reevaluation of collective consciousnesses that surrounds nuclear power.

As the Vice President of Public Policy at C3 Solutions, Nick Loris has the knowledgeable expertise on the energy debate. With a focus on free-market environmentalism, Loris’ work seeks to navigate the complex interplay between public policy, energy resources, and environmental protection. This knowledge enables him to elaborate on where misinformation can interfere with the perception of nuclear energy and the future of its research.

Loris’ Thoughts

“What we’re seeing in response from places like China and Taiwan and South Korea in terms of continuing to ban the importation of seafood from Japan is emblematic of the larger problem with nuclear power, and that is that the public perception of risk is far greater than the actual risk. Japan’s release of wastewater from the Fukushima power plant into the ocean is extremely safe and extremely low risk. The water has been treated multiple times, and the level of radioactivity is far below any limits set and will pose negligible impacts on human health and the environment. 

“In fact, the level of radioactivity is only about two percent of what the limit is for safe drinking water set by the World Health Organization. What we’re seeing in response from places like China and Taiwan and South Korea in terms of continuing to ban the importation of seafood from Japan is emblematic of the larger problem with nuclear power, and that is that the public perception of risk is far greater than the actual risk. The reality is nuclear power is among the cleanest and safest forms of energy that we have on the planet today, and if we are to meet our needs in terms of providing affordable, reliable energy and meeting our emissions targets to reduce the effects and impacts of climate change, nuclear power will play an integral role in accomplishing both.”

Article written by Alexandra Simon.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

Nick Loris
Nick LorisVice President of Public Policy

You can write about your years of experience, industry, or skills. (Feel free to copy and paste your LinkedIn 'About' info here).

B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Clinical data harmonization is the bottleneck for life sciences AI

Clinical data harmonization is the bottleneck for life sciences AI

Life sciences companies moving AI from experimentation to scale keep running into messy trial data. One study can draw on EDC, health records, eCOA tools, wearables and imaging, and data teams at pharma SMEs often spend up to 80% of their time wrangling it. Commentators point to lakehouse architectures and data-cleansing AI agents, though the agents are still at proof of concept.

  • 01Treat automation gains as proof-of-concept for now; evaluate AI/harmonization choices based on data readiness, governance, and whether the architecture supports traceability and regulatory needs.

Sep 26, 2026

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

Contract Pharma reports bioTRAK data projecting CDMOs will install roughly 120 bioreactors by 2030. It says 71% of added volume is large-scale stainless steel, while 61% of systems are single-use.

  • 01Utilization discipline is still driving builds: BioTRAK’s Dawn Ecker told Contract Pharma expansion conversations typically start after a site is booked above ~80% for several years.

Sep 22, 2026

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

Nick Loris
Nick Loris

Vice President of Public Policy

You can write about your years of experience, industry, or skills. (Feel free to copy and paste your LinkedIn 'About' info here).

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512